A New Frontier in HPP Research Recent clinical trial findings have shed light on a potential breakthrough for patients living with hypophosphatasia (HPP), a rare and serious genetic disorder. Data recently released regarding efzimfotase alfa—an investigational enzyme replacement therapy—suggests a meaningful step forward in managing the physical limitations associated with this condition. Understanding the Clinical…